SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-08-000033
Filing Date
2008-05-28
Accepted
2008-05-28 13:55:01
Documents
1
Period of Report
2008-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 19041
  Complete submission text file 0000875320-08-000033.txt   20818
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 100 EUROPA DRIVE STE 170 CHAPEL HILL NC 27514
Business Address 100 EUROPA DRIVE SUITE 170 CHAPEL HILL NC 27514 9199326998
SANDERS CHARLES A (Reporting) CIK: 0001022936 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 08863082